BRPI0411239A - composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto - Google Patents

composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto

Info

Publication number
BRPI0411239A
BRPI0411239A BRPI0411239-3A BRPI0411239A BRPI0411239A BR PI0411239 A BRPI0411239 A BR PI0411239A BR PI0411239 A BRPI0411239 A BR PI0411239A BR PI0411239 A BRPI0411239 A BR PI0411239A
Authority
BR
Brazil
Prior art keywords
compound
treating
preventing
pharmaceutical composition
potassium channel
Prior art date
Application number
BRPI0411239-3A
Other languages
English (en)
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Original Assignee
Xention Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Discovery Ltd filed Critical Xention Discovery Ltd
Publication of BRPI0411239A publication Critical patent/BRPI0411239A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO, PROCESSO PARA PREPARAR O MESMO, COMPOSIçãO FARMACêUTICA, MéTODO PARA TRATAR OU PREVENIR UM DISTúRBIO QUE REQUER INIBIçãO DE CANAL DE POTáSSIO, E, USO DE UM COMPOSTO". A presente invenção provê compostos de tienopirimidina que são inibidores de canais de potássio. As composições farmacêuticas compreendendo os compostos e seu uso no tratamento de arritmias são também providas.
BRPI0411239-3A 2003-06-11 2004-06-10 composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto BRPI0411239A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
BRPI0411239A true BRPI0411239A (pt) 2006-07-18

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411239-3A BRPI0411239A (pt) 2003-06-11 2004-06-10 composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto

Country Status (15)

Country Link
EP (1) EP1641803B3 (pt)
KR (1) KR101186678B1 (pt)
CN (1) CN1823071B (pt)
AT (1) ATE425982T1 (pt)
AU (1) AU2004247470B2 (pt)
BR (1) BRPI0411239A (pt)
CA (1) CA2528848C (pt)
DE (1) DE602004020070D1 (pt)
DK (1) DK1641803T3 (pt)
ES (1) ES2324536T7 (pt)
MX (1) MXPA05013549A (pt)
PL (1) PL1641803T6 (pt)
SI (1) SI1641803T1 (pt)
WO (1) WO2004111057A1 (pt)
ZA (1) ZA200600225B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
JP2008505084A (ja) * 2004-06-29 2008-02-21 アムゲン インコーポレイティッド フラノピリミジン
EP1802632B1 (en) * 2004-10-21 2011-07-13 Dow AgroSciences LLC Thieno-pyrimidine compounds having fungicidal activity
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) * 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
US8883852B2 (en) 2008-10-22 2014-11-11 University of Pittburgh—Of the Commonwealth System of Higher Education Radioprotective agents
ES2665277T3 (es) 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Análogos de purina y su uso como agentes inmunosupresores
ES2900504T3 (es) 2009-09-03 2022-03-17 Bristol Myers Squibb Co Quinazolinas como inhibidores de los canales iónicos de potasio
CA2790284C (en) * 2010-02-17 2019-01-08 Takeda Pharmaceutical Company Limited Thieno-pyrimidine compounds having cdc7 inhibitory activity
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (pt) 2011-07-01 2018-04-28
EP2780344A1 (en) * 2011-11-15 2014-09-24 Xention Limited Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
CA2855446C (en) 2011-11-23 2021-04-20 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase c
NZ627942A (en) 2012-01-27 2016-03-31 Gilead Sciences Inc Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
KR20150128768A (ko) * 2013-03-07 2015-11-18 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 티에노[3,2-d]피리미딘-6-카르복스아미드 및 유사체
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
CA3066939A1 (en) * 2017-06-21 2018-12-27 SHY Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
EP3898609A1 (en) 2018-12-19 2021-10-27 Shy Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
WO2001046155A1 (en) 1999-12-21 2001-06-28 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
PL1641803T3 (pl) 2009-08-31
DE602004020070D1 (de) 2010-10-07
AU2004247470B2 (en) 2009-04-23
HK1093064A1 (en) 2007-02-23
SI1641803T1 (sl) 2009-08-31
ATE425982T1 (de) 2009-04-15
PL1641803T6 (pl) 2011-04-29
AU2004247470A1 (en) 2004-12-23
KR20060057539A (ko) 2006-05-26
CA2528848A1 (en) 2004-12-23
KR101186678B1 (ko) 2012-09-27
CN1823071B (zh) 2012-12-19
ES2324536T7 (es) 2012-03-16
CN1823071A (zh) 2006-08-23
EP1641803A1 (en) 2006-04-05
EP1641803B1 (en) 2009-03-18
EP1641803B3 (en) 2010-12-08
ZA200600225B (en) 2007-04-25
DK1641803T3 (da) 2009-06-29
MXPA05013549A (es) 2006-04-05
ES2324536T3 (es) 2009-08-10
CA2528848C (en) 2012-09-04
WO2004111057A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
SG164368A1 (en) Treatment of cancer
BRPI0414533A (pt) composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
BRPI0410117A (pt) composto, composição farmacêutica, método para o tratamento de uma doença ou condição mediada por jak3, e, processo para a preparação de um composto
WO2004078117A3 (en) Method for increasing hair growth
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
SV2009003227A (es) Composiciones de inhibidores de chk 1 ref. x-17672
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
BRPI0413255A (pt) uso de uma combinação de um inibidor de quinase do receptor do fator de crescimento epidérmico e agentes citotóxicos para tratamento e inibição do cáncer
IL190632A0 (en) Biphenyl derivatives and pharmaceutical compositions containing the same
MY162174A (en) Azetidines mek inhibitors for the treatment of proliferative diseases
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
DE60329326D1 (de) Tace inhibitoren
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
BR0312470A (pt) Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto
BRPI0517032A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e utilização desses compostos
WO2005041904A3 (en) Inhibitors of coronavirus protease and methods of use thereof
WO2004060878A3 (en) Inhibitors of phosphatases
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
BRPI0408238A (pt) anticorpo, método de detectar cáncer, conjunto para detecção de cáncer, e, composição farmacêutica para tratar cáncer
BRPI0409768A (pt) composto, uso de composto, composição farmacêutica, método para tratar e/ou prevenir cáncer, e, processo para preparar o composto
DE60312988D1 (de) Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]

Free format text: ELIMINAR ALGUMAS REIVINDICACOES, FALTA DE CLAREZA DAS REIVINDICACOES (ART. 25), OUTROS

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements